Our team’s focus is on relationships with early-stage innovative companies across the world in our thematic areas of interest.
 

From our experience, successful engagements often start with companies that meet the following criteria:

For business-sponsored collaborations and investments:

 

• Well-rounded and experienced founding team
• Seed level and above, to Series B
• Clearly defined and validated solution
• Regulatory pathway completed or in progress
• In-line with the Philips focus areas
• While geographically agnostic; proximity to relevant Philips sites does support collaboration
  
  

For the Philips Health Technology Venture Fund:

• Series A/B stage
• Initial investment of $2 million – $5 million EUR/USD, reserves at twice initial investment
• We syndicate all deals
• Company maturity at early commercial stage
• Investment goal is to confirm product validation / value proposition and drive scale